SAN FRANCISCO --- A San Francisco-based pharmaceutical company is bringing a new contraceptive to the U.S. market. The product is Liletta, an intrauterine device (IUD), which, like any other IUD, is long-lasting and highly effective at preventing pregnancy when inserted properly. However, the story here is not the product -- it’s the company’s
Pharmaceutical Company Operates With The Heart Of A Nonprofit, Soul Of Social Enterprise
“We’re showing the pharmaceutical industry that there’s another model,” the company’s COO says, explaining how Medicines360 is able to sustain its operations via sales, not donations.